Novel Inhalational Murine Model of Invasive Pulmonary Aspergillosis
AUTOR(ES)
Sheppard, Donald C.
FONTE
American Society for Microbiology
RESUMO
We developed a novel model of invasive aspergillosis (IA) that recapitulates human disease. Mice were immunosuppressed with cyclophosphamide and cortisone acetate and then infected in an aerosol chamber. This procedure reproducibly delivered 1 × 103 to 3 × 103 conidia to the lungs. Lethal pulmonary IA developed over 2 weeks and was prevented by amphotericin B.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=400587Documentos Relacionados
- Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection.
- Protective Role of Lung Surfactant Protein D in a Murine Model of Invasive Pulmonary Aspergillosis
- Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
- Bronchoscopy findings in invasive pulmonary aspergillosis.
- Efficacy of TAK-457, a Novel Intravenous Triazole, against Invasive Pulmonary Aspergillosis in Neutropenic Mice